Goldman Sachs Group Inc Maravai Lifesciences Holdings, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,038,548 shares of MRVI stock, worth $11.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,038,548

Previous 420,397 384.91%

Holding current value

$11.4 Million

Previous $3.01 Million 462.79%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.84 - $9.73 $11.1 Million - $15.7 Million	1,618,151 Added 384.91%	2,038,548 $16.9 Million
Q2 2024 Aug 13, 2024	BUY	$6.87 - $11.34 $1.52 Million - $2.51 Million	221,130 Added 110.97%	420,397 $3.01 Million
Q1 2024 May 15, 2024	SELL	$5.11 - $8.76 $11,553 - $19,806	-2,261 Reduced 1.12%	199,267 $1.73 Million
Q4 2023 Feb 13, 2024	SELL	$4.7 - $9.87 $186,937 - $392,569	-39,774 Reduced 16.48%	201,528 $1.32 Million
Q3 2023 May 14, 2024	BUY	$9.14 - $12.85 $363,534 - $511,095	39,774 Added 19.74%	241,302 $2.41 Million
Q3 2023 Nov 14, 2023	BUY	$9.14 - $12.85 $721,977 - $1.02 Million	78,991 Added 48.67%	241,302 $2.41 Million
Q2 2023 May 14, 2024	SELL	$12.09 - $15.0 $2.61 Million - $3.23 Million	-215,542 Reduced 57.04%	162,311 $2.02 Million
Q2 2023 Aug 14, 2023	SELL	$12.09 - $15.0 $2.61 Million - $3.23 Million	-215,542 Reduced 57.04%	162,311 $2.02 Million
Q1 2023 May 14, 2024	SELL	$12.99 - $16.48 $7.66 Million - $9.71 Million	-589,443 Reduced 60.94%	377,853 $5.29 Million
Q1 2023 May 11, 2023	SELL	$12.99 - $16.48 $7.66 Million - $9.71 Million	-589,443 Reduced 60.94%	377,853 $5.29 Million
Q4 2022 May 14, 2024	BUY	$12.5 - $24.78 $7.35 Million - $14.6 Million	587,745 Added 154.85%	967,296 $13.8 Million
Q4 2022 Feb 13, 2023	BUY	$12.5 - $24.78 $7.35 Million - $14.6 Million	587,745 Added 154.85%	967,296 $13.8 Million
Q3 2022 May 14, 2024	BUY	$20.6 - $30.37 $1.12 Million - $1.65 Million	54,277 Added 16.69%	379,551 $9.69 Million
Q3 2022 Nov 10, 2022	BUY	$20.6 - $30.37 $1.12 Million - $1.65 Million	54,277 Added 16.69%	379,551 $9.69 Million
Q2 2022 May 14, 2024	BUY	$26.05 - $37.48 $3.22 Million - $4.64 Million	123,746 Added 61.4%	325,274 $9.24 Million
Q2 2022 Aug 15, 2022	BUY	$26.05 - $37.48 $1.09 Million - $1.57 Million	41,846 Added 14.76%	325,274 $9.24 Million
Q1 2022 May 16, 2022	SELL	$24.46 - $40.92 $779,564 - $1.3 Million	-31,871 Reduced 10.11%	283,428 $10 Million
Q4 2021 Feb 14, 2022	BUY	$35.0 - $45.94 $6.84 Million - $8.98 Million	195,439 Added 163.06%	315,299 $13.2 Million
Q3 2021 Nov 10, 2021	BUY	$36.8 - $60.62 $4.41 Million - $7.27 Million	119,860 New	119,860 $5.88 Million

Others Institutions Holding MRVI

# of Institutions

234

Shares Held

140M

Call Options Held

223K

Put Options Held

19.4K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $738M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Maravai Lifesciences Holdings, Inc. Transaction History